Transforming legacy approaches to understanding drug costs: An Interview with HealthPlanView’s Nicole Espinoza
Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Nicole Espinoza, Vice President of Knowledge Management at Pharmspective, a Healthcare [...]
Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?
While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers (PBMs) have [...]
CVS Caremark’s foray into cost-effectiveness analysis raises questions about the future of prescription medicines in America
Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, [...]
Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.
Swarali Tadwalker, MPH Hardly a day goes by without a new article being published in the mainstream press [...]
Advertisement
